Menstrual variation of autonomic balance may be a factor in exacerbations of certain diseases during the menstrual cycle

Medical Hypotheses

Volumn 63, Issue 1, 2004, Pages 163-167

  Lee, Patrick Y ^a   Bazar, Kimberly A ^b   Yun, A Joon ^a  

^a STANFORD UNIVERSITY   (United States)

^b San Mateo County Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; NORADRENALIN; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ADRENERGIC ACTIVITY; APOPTOSIS; AUTONOMIC NERVOUS SYSTEM; CELLULAR IMMUNITY; DISEASE EXACERBATION; GASTROINTESTINAL TRANSIT; GLAUCOMA; HEART RATE VARIABILITY; HORMONAL REGULATION; HUMAN; KIDNEY BLOOD FLOW; LYMPHATIC SYSTEM; MENSTRUAL CYCLE; MIGRAINE; MOLECULAR EVOLUTION; MYASTHENIA GRAVIS; NIDATION; PREGNANCY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCTION; REVIEW; SLEEP DISORDER; SUPRAVENTRICULAR TACHYCARDIA; SYMPATHETIC TONE; TH1 CELL; TH2 CELL; VAGINITIS;

EID: 3042762515     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.036     Document Type: Article

References (79)

1. Rosano G.M., Leonardo F., Sarrel P.M., Beale C.M., De Luca F., Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet. 347:1996;786-788
2. Mannix L.K. Management of menstrual migraine. Neurology. 9:2003;207-213
3. Foldvary-Schaefer N., Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology. 61(6 Suppl. 2):2003;S2-S15
4. Manber R., Bootzin R.R. Sleep and the menstrual cycle. Health Psychol. 16:1997;209-214
5. Wyman J.B., Heaton K.W., Manning A.P., et al. Variability of colonic function in healthy subjects. Gut. 19:1978;146-150
6. Wald A., Thiel D.H., Hoechstetter L., et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology. 80:1981;1497-1500
7. Greenstein D., Jeffcote N., Ilsley D., Kester R.C. The menstrual cycle and Raynaud's phenomenon. Angiology. 47:1996;427-436
8. Paterson G.D., Miller S.J.H. Hormonal influence in simple glaucoma. Br. J. Ophthalmol. 47:1963;129-137
9. Dalton K. Influence of menstruation on glaucoma. Br. J. Ophthalmol. 51:1967;692-695
10. Lande R.G., Karamchandani V. Chronic mental illness and the menstrual cycle. J. Am. Osteopath Assoc. 102:2002;655-659
11. Roy S.K., Ghosh B.P., Bhattacharjee S.K. Changes in oral glucose tolerance during normal menstrual cycle. J. Ind. Med. Assoc. 57:1971;201-204
12. Letterie G.S., Fredlund P.N. Catamenial insulin reactions treated with a long-acting gonadotropin-releasing hormone agonist. Arch. Intern. Med. 154:1994;1868-1870
13. Widom B., Diamond M.P., Simonson D.C. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care. 15:1992;213-220
14. Mostad S.B., Kreiss J.K., Ryncarz A., et al. Cervical shedding of herpes simplex virus and cytomegalovirus throughout the menstrual cycle in women infected with human immunodeficiency virus type 1. Am. J. Obstet. Gynecol. 183:2000;948-955
15. Hanna L. The menstrual cycle and viral load. BETA. 12:1999;18
16. Mysliwska J., Trzonkowski P., Bryl E., Lukaszuk K., Mysliwski A. Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women. Eur. Cytokine Netw. 11:2000;397-406
17. Corrigan E.M., Clancy R.L., Dunkley M.L., Eyers F.M., Beagley K.W. Cellular immunity in recurrent vulvovaginal candidiasis. Clin. Exp. Immunol. 111:1998;574-578
18. Gibbs C.J., Counts I.I., Lock R., et al. Premenstrual exacerbations of asthma. Thorax. 39:1984;833-836
19. Eliasson O., Scherzer H.H. Recurrent respiratory failure in premenstrual asthma. Conn. Med. 48:1984;777
20. Eliasson O., Scherzer H., DeGraff A.C. Morbidity in asthma in relation to the menstrual cycle. J. Allergy Clin. Immunol. 77:1986;87-94
21. Lam S.M., Huang S.C. Premenstrual asthma: report of a case with hormonal studies. J. Microbiol. Immunol. Infect. 31:1998;197-199
22. Hanley S.P. Asthma variation with menstruation. Br. J. Dis. Chest. 75:1981;306-308
23. Case A.M., Reid R.L. Effects of the menstrual cycle on medical disorders. Arch. Intern. Med. 158:1998;1405-1412
24. Boggess K.A., Williamson H.O., Homm R.J. Influence of the menstrual cycle on systemic diseases. Obstet. Gynecol. Clin. North Am. 17:1990;321-342
25. Oskay T., Kutluay L., Kaptanoglu A., Karabacak O. Autoimmune progesterone dermatitis. Eur. J. Dermatol. 12:2002;589-591
26. James M.P., Williams R.M. Benign familial pemphigus - premenstrual exacerbation suppressed by goserelin and oophorectomy. Clin. Exp. Dermatol. 20:1995;54-55
27. Kiriyama K., Sugiura H., Uehara M. Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatology. 206:2003;110-112
28. Snyder J.L., Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann. Allergy Asthma Immunol. 90:2003;469-477
29. Keane F.E., Ison C.A., Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int. J. STD AIDS. 8:1997;489-494
30. Cutolo M., Sulli A., Seriolo B., Accardo S., Masi A.T. Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13:1995;217-226
31. Buggage R.R., Matteson D.M., de Shen F., Sun B., Tuaillon N., Chan C.C. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol. Invest. 32:2003;259-273
32. Refojo D., Liberman A.C., Giacomini D., et al. Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann. N. Y. Acad. Sci. 992:2003;196-204
33. Wilder R.L Hormones, pregnancy, and autoimmune diseases. Ann. N. Y. Acad. Sci. 840:1998;45-50
34. Guasti L., Grimoldi P., Mainardi L.T., et al. Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans. Acta Cardiol. 54:1999;209-213
35. Yildirir A., Kabakci G., Akgul E., Tokgozoglu L., Oto A. Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Ann. Noninvasive Electrocardiol. 7:2002;60-63
36. Spaanderman M.E., Van Beek E., Ekhart T.H., Van Eyck J., Cheriex E.C., De Leeuw P.W., et al. Changes in hemodynamic parameters and volume homeostasis with the menstrual cycle among women with a history of preeclampsia. Am. J. Obstet Gynecol. 182:2000;1127-1134
37. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians. 108:1996;374-381
38. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97:1996;713-719
39. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur. J. Immunol. 26:1996;2601-2605
40. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., et al. Beta 2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1997;1513-1519
41. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638
42. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 966:2002;290-303
43. Hassig A., Kremer H., Liang W.X., Stampfli K. The role of the Th-1 to Th-2 shift of the cytokine profiles of CD4 helper cells in the pathogenesis of autoimmune and hypercatabolic diseases. Med. Hypotheses. 51:1998;59-63
44. Leussink V.I., Jung S., Merschdorf U., Toyka K.V., Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch. Neurol. 58:2001;91-97
45. Tsuda H., Michimata T., Sakai M., Nagata K., Nakamura M., Saito S. A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy. Clin. Exp. Immunol. 123:2001;105-111
46. Ekerfelt C., Lidstrom C., Matthiesen L., Berg G., Sharma S., Ernerudh J. Spontaneous secretion of interleukin-4, interleukin-10 and interferon-gamma by first trimester decidual mononuclear cells. Am. J. Reprod. Immunol. 47:2002;159-166
47. Kwak-Kim J.Y., Chung-Bang H.S., Ng S.C., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum. Reprod. 18:2003;767-773
48. Lim K.J., Odukoya O.A., Ajjan R.A., Li T.C., Weetman A.P., Cooke I.D. The role of T-helper cytokines in human reproduction. Fertil. Steril. 73:2000;136-142
49. Carp H., Torchinsky A., Fein A., Toder V. Hormones, cytokines and fetal anomalies in habitual abortion. Gynecol. Endocrinol. 15:2001;472-483
50. Gleicher N. Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses. Am. J. Reprod. Immunol. 48:2002;252-254
51. Jayawardana M.A. Baroreceptor sensitivity and haemodynamics in normal pregnancy. J. Obstet. Gynaecol. 21:2001;559-562
52. Watanabe M., Nakagawa M., Nobe S., Ohie T., Takahashi N., Hara M., et al. Circadian variation of short-lasting asymptomatic paroxysmal supraventricular tachycardia. J. Electrocardiol. 35:2002;135-138
53. Ablad B., Dahlof C. Migraine and beta-blockade: modulation of sympathetic neurotransmission. Cephalalgia. 6(Suppl 5):1986;7-13
54. Montagna P., Gambetti P., Cortelli P., Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol. 2:2003;167-176
55. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and management. Colorectal. Dis. 5:2003;288-296
56. Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin. Proc. 78:2003;603-612
57. Riccadonna M., Covi G., Pancera P., et al. Autonomic system activity and 24-h blood pressure variations in subjects with normal- and high-tension glaucoma. J. Glaucoma. 12:2003;156-163
58. Ostrowski S.R., Gerstoft J., Pedersen B.K., Ullum H. Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients. AIDS. 17:2003;521-530
59. Norbiato G., Bevilacqua M., Vago T., Clerici M. Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin. Exp. Rheumatol. 15:1997;315-323
60. Essa S., Raghupathy R., Pacsa A.S., El-Shazly A., Said T., Azizieh F. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J. Med. Virol. 60:2000;223-229
61. Fidel P.L. Jr. Immunity to Candida. Oral Dis. 8(Suppl 2):2002;69-75
62. Chantry D., Burgess L.E. Chemokines in allergy. Curr. Drug Targets Inflamm. Allergy. 1:2002;109-116
63. Vestergaard C., Deleuran M., Gesser B., Larsen Gronhoj C. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br. J. Dermatol. 149:2003;457-463
64. Gangur V., Birmingham N.P., Thanesvorakul S., Joseph S. CCR3 and CXCR3 as drug targets for allergy: principles and potential. Curr. Drug Targets Inflamm. Allergy. 2:2003;53-62
65. Akdis M., Trautmann A., Klunker S., et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J. 17:2003;1026-1035
66. Jenmalm M.C., Van Snick J., Cormont F., Salman B. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children. Clin. Exp. Allergy. 31:2001;1528-1535
67. Aridogan B.C., Yildirim M., Baysal V., Inaloz H.S., Baz K., Kaya S. Serum evels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease. J. Dermatol. 30:2003;602-607
68. Friedmann P.S. The pathogenesis of atopic eczema. Hosp. Med. 63:2002;653-656
69. Miescher S.M., Vogel M. Molecular aspects of allergy. Mol. Aspects Med. 23:2002;413-462
70. Caproni M., Giomi B., Cardinali C., et al. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin. Immunol. 98:2001;264-271
71. Muller N., Riedel M., Gruber R., Ackenheil M., Schwarz M.J. The immune system and schizophrenia. An integrative view. Ann. N. Y. Acad. Sci. 917:2000;456-467
72. Lagathu C., Bastard J.P., Auclair M., Maachi M., Capeau J., Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun. 311:2003;372-379
73. Shibasaki M., Takahashi K., Itou T., Bujo H., Saito Y. A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice. Biochem. Biophys. Res. Commun. 309:2003;419-424
74. Sasaki S., Nishikawa S., Miura T., et al. Interleukin-4 and interleukin-10 are involved in host resistance to staphylococcus aureus infection through regulation of gamma interferon. Infect. Immun. 68:2000;2424-2430
75. Souroujon M.C., Maiti P.K., Feferman T., Im S.H., Raveh L., Fuchs S. Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors. Ann. N. Y. Acad. Sci. 998:2003;533-536
76. Aarli J.A. Role of cytokines in neurological disorders. Curr. Med. Chem. 10:2003;1931-1937
77. Wang H.B., Li H., He B., et al. The role of B-cells in experimental myasthenia gravis in mice. Biomed. Pharmacother. 53(5-6):1999;227-233
78. Vijayan N., Vijayan V.K., Dreyfuss P.M. Acetylcholinesterase activity and menstrual remissions in myasthenia gravis. J. Neurol. Neurosurg. Psychiatry. 40:1977;1060-1065
79. Leker R.R., Karni A., Abramsky O. Exacerbation of myasthenia gravis during the menstrual period. J. Neurol. Sci. 156:1998;107-111